Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction

被引:56
|
作者
Cardoso, Rosa [1 ]
Love, Robert [1 ]
Nilsson, Carol L. [1 ]
Bergqvist, Simon [2 ]
Nowlin, Dawn [2 ]
Yan, Jiangli [1 ]
Liu, Kevin K. -C. [1 ]
Zhu, Jing [3 ]
Chen, Ping [1 ]
Deng, Ya-Li [1 ]
Dyson, H. Jane [3 ]
Greig, Michael J. [1 ]
Brooun, Alexei [1 ]
机构
[1] Pfizer Inc, Oncol Chem, Worldwide Res & Dev, San Diego, CA 92121 USA
[2] Pfizer Inc, Oncol Res Unit, Worldwide Res & Dev, San Diego, CA 92121 USA
[3] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
关键词
protein-protein interaction (PPI); crystal structure; covalent inhibitor; NMR spectroscopy; mass spectrometry; AlphaScreen; surface plasmon resonance (SPR); isothermal titration calorimetry (ITC); HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; LIGAND-BINDING; CDDO-ME; KINASE; HIF-1; HETERODIMERIZATION; DISCOVERY; RECEPTOR;
D O I
10.1002/pro.2172
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heterodimer HIF-1a (hypoxia inducible factor)/HIF-beta (also known as ARNT-aryl hydrocarbon nuclear translocator) is a key mediator of cellular response to hypoxia. The interaction between these monomer units can be modified by the action of small molecules in the binding interface between their C-terminal heterodimerization (PasB) domains. Taking advantage of the presence of several cysteine residues located in the allosteric cavity of HIF-1a PasB domain, we applied a cysteine-based reactomics hotspot identification strategy to locate regions of HIF-1a PasB domain critical for its interaction with ARNT. COMPOUND 5 was identified using a mass spectrometry-based primary screening strategy and was shown to react specifically with Cys255 of the HIF-1a PasB domain. Biophysical characterization of the interaction between PasB domains of HIF-1a and ARNT revealed that covalent binding of COMPOUND 5 to Cys255 reduced binding affinity between HIF-1a and ARNT PasB domains approximately 10-fold. Detailed NMR structural analysis of HIF-1a-PasB-COMPOUND 5 conjugate showed significant local conformation changes in the HIF-1a associated with key residues involved in the HIF-1a/ARNT PasB domain interaction as revealed by the crystal structure of the HIF-1a/ARNT PasB heterodimer. Our screening strategy could be applied to other targets to identify pockets surrounding reactive cysteines suitable for development of small molecule modulators of protein function.
引用
收藏
页码:1885 / 1896
页数:12
相关论文
共 50 条
  • [41] HIF-1α protein is increased in the retina of a neonatal rat model of retinopathy
    Madan, A
    Bergeron, M
    Stevenson, DK
    Penn, JS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S975 - S975
  • [42] Inhibitory effect of 6-formylpterin on HIF-1α protein accumulation
    Sommani, Piyanart
    Yamashita, Kouhei
    Miyoshi, Takashi
    Tsunemine, Hiroko
    Kodaki, Tsutomu
    Mori, Hiroko
    Hirota, Kiichi
    Arai, Toshiyuki
    Sasada, Masataka
    Makino, Keisuke
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (11) : 2181 - 2184
  • [43] Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein
    Song, Xiuming
    Yao, Jing
    Wang, Fei
    Zhou, Mi
    Zhou, Yuxin
    Wang, Hu
    Wei, Libin
    Zhao, Li
    Li, Zhiyu
    Lu, Na
    Guo, Qinglong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 271 (02) : 144 - 155
  • [44] Expression and clinical significance of HIF-1 a protein in hepatocellular carcinoma tissues
    丁磊
    陈孝平
    王海平
    中华肝脏病杂志, 2004, (11) : 21 - 24
  • [45] Developmental ontogeny of HIF-1 mRNA and protein in the mouse eye.
    Balsubramanian, S
    Varma, S
    Stevenson, DK
    Madan, A
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 94A - 94A
  • [46] Isolation and identification of novel natural products that inhibit P300/HIF-1α interaction
    Chan, S. T. S.
    Patel, P. R.
    Martin, G. E.
    Williamson, R. T.
    Sauri, J.
    Buevich, A., V
    Ransom, T. R.
    Henrich, C. J.
    McKee, T. C.
    Figg, W. D.
    McMahon, J. B.
    Schnermann, M. J.
    Gustafson, K. R.
    PLANTA MEDICA, 2015, 81 (11) : 909 - 909
  • [47] Identification of a new natural camptothecin analogue in targeted screening for HIF-1α inhibitors
    Klausmeyer, Paul
    McCloud, Thomas G.
    Melillo, Giovanni
    Scudiero, Dominic A.
    Cardellina, John H., II
    Shoemaker, Robert H.
    PLANTA MEDICA, 2007, 73 (01) : 49 - 52
  • [48] A domain responsible for HIF-1α degradation by YG-1, a novel anticancer agent
    Kim, Hye-Lim
    Yeo, Eun-Jin
    Chun, Yang-Sook
    Park, Jong-Wan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (01) : 255 - 260
  • [49] Development of a novel fluorescent imaging probe for tumor hypoxia by use of a fusion protein with oxygen-dependent degradation domain of HIF-1α
    Tanaka, Shotaro
    Kizaka-Kondoh, Shinae
    Harada, Hiroshi
    Hiraoka, Masahiro
    GENETICALLY ENGINEERED AND OPTICAL PROBES FOR BIOMEDICAL APPLICATIONS IV, 2007, 6449
  • [50] Preclinical evaluation of novel HIF-1α/P300 binding inhibitors
    Strope, Jonathan D.
    Harris, Emily M.
    Beedie, Shaunna L.
    Chau, Cindy H.
    Cook, Kristina M.
    Schofield, Christopher J.
    Gustafson, Kirk R.
    Figg, William D.
    CANCER RESEARCH, 2018, 78 (13)